.png)
.svg)
June 11, 2024
FluoSphera and Revvity Collaborate to Develop a Multiplexed Selectivity Assay for In Vitro Drug Discovery
FluoSphera and Revvity Collaborate to Develop a Multiplexed Selectivity Assay for In Vitro Drug Discovery
Read Article
FluoSphera
Take the Control of Your Drug Discovery Pipeline
Predict the systemic drug response
The role of blood is to connect all the organs in the human body, enabling constant communication and functioning as a fully integrated system. These systemic interactions ultimately determine the clinical outcomes of drugs. FluoSphera is the first technology designed to analyze and predict these systemic communications for drug discovery.
Next-Generation Drug Discovery
Human Multi-Tissue Systems
FluoSphera has developed a cutting-edge technology platform to discover new drugs with human multi-tissue systems faithfully mimicking clinical drug responses. This enables high-resolution drug profiling before clinical trials, with strong human and systemic relevance.
Integrated Discovery Product
Discovery of the most selective therapies
Connections
We partner with
News
Articles & Resources
FluoSphera's technology is a multi-organoid system that combines encapsulated tissues to mimic the complex human system, enabling reliable in vitro drug discovery.
Enter your email for an exclusive trial
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
FluoSphera SA
c/o Fongit, Route de la Galaise 34
1228 Plan-les-Ouates
c/o Fongit, Route de la Galaise 34
1228 Plan-les-Ouates
FluoSphera Discovery Inc.
100 Cambridge Street, 14th floor
Boston, MA 02114
100 Cambridge Street, 14th floor
Boston, MA 02114
.svg)
